Bunge Global S.A. (BG) Stock Analysis

68.0/100
Buy Not Halal Consumer Defensive
Price $101.65
Market Cap $19.53B
52-Week Change +4.90%

Is BG a good investment?

Bunge Global S.A. (BG) has a Plutrex AI rating of 68.0/100 as of November 14, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 1.03 is 55% below the industry average of 2.29 — BG offers dramatically more growth per unit of P/E paid versus any peer; combined with P/E of 17.09x on 17% forward EPS growth, this is the most attractively priced growth stock in the Agricultural Farm Products sector. Main concern: Negative FCF of -$2.656 billion against cash of $890 million — the company cannot self-fund operations; D/E of 0.61 (43% above peer average 0.43) means external financing relies on debt markets; continued cash burn compounds balance sheet fragility especially in a commodity downturn.

Investment Summary

Bunge Global (BG) at $101.65 presents a compelling growth-at-value proposition in the Agricultural Farm Products sector, anchored by a PEG ratio of 1.03 (55% discount to industry average of 2.29) and forward EPS growth of 17.0% next year — 9.6% above peer average. The P/E of 17.09x on 17% growth, combined with P/B of 1.20x (near tangible book), creates a valuation case that analyst consensus validates with a $155.00 target implying 52.5% upside. However, two structural concerns remain unresolved: (1) Negative FCF of -$2.656 billion — the company is not self-funding, requiring external capital; (2) Net margin of only 1.24% (32% below peer average of 1.83%), leaving no buffer for commodity price adversity. News sentiment is exceptionally strong at 92.4/100 — BG maintained its full-year 2026 earnings outlook, beat Q3 profit estimates on strong crush margins, and announced the Enerseed joint venture with GDM for novel oilseed development. The stock has recovered 5.9% from prior report's $96.02 to $101.65 but remains far below the analyst target. This is a growth leader at a value price in a structurally challenged commodity business — investable with discipline.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
32/100
Growth Potential
82/100
Valuation
82/100
Profitability
25/100
Debt Management
35/100
Analyst Sentiment
78/100
Technical Momentum
52/100
Insider Confidence
55/100
News Sentiment
88/100

Fundamental Analysis

BG operates in the classic low-margin, high-volume agricultural commodity trading model. Gross margin of 6.06% (vs. industry 6.73%) and net margin of 1.24% (vs. industry 1.83%) reflect structural commodity price pass-through dynamics — not weakness unique to BG but characteristic of ABCD grain traders. ROE of 7.23% matches industry precisely (industry: 7.22%), confirming BG generates adequate capital returns relative to peers despite thin margins. The critical concern is negative FCF of -$2.656 billion against cash of $890 million — a structural liquidity deficit that requires either debt financing or asset monetization. D/E of 0.61 is moderate in absolute terms but 43% above peer average of 0.43, compounding the FCF concern. On the positive side: forward EPS growth of 17.0% (next year) and 16.6% (5-year CAGR) are sector-leading. P/E of 17.09x against 17% growth yields a PEG of 1.03 — essentially fair value with a slight undervaluation lean. P/B of 1.20x (~$84.70/share book value) provides meaningful asset-backed downside support. The revenue growth of 7.4% (vs. industry 4.98%) confirms BG is gaining volume and market share within the peer group. The 94.7% historical EPS growth spike likely reflects a commodity cycle inflection point — the normalized forward 17% growth rate is more sustainable and what drives the valuation.

News Sentiment

Bunge Global is quietly building a compelling comeback story — and Wall Street is starting to take notice. The agricultural trading giant, one of the world's largest processors of soybeans and other oilseeds, has been delivering the goods operationally even as its stock price has struggled to reflect that reality. The company recently beat quarterly profit estimates on the back of strong crush margins — the lucrative spread between raw commodity prices and processed products like soybean oil and meal. That's the core engine of Bunge's profitability, and it's firing. Perhaps most reassuringly for investors, Bunge maintained its full-year 2026 earnings outlook, signaling management confidence in sustained performance through year-end — no earnings warnings, no guidance cuts, just affirmation of a profitable path forward. The company is also planting seeds — literally — for future growth. Bunge announced the formation of Enerseed, a joint venture with GDM that combines Bunge's global agricultural expertise with GDM's cutting-edge seed genetics and breeding capabilities to develop novel oilseeds. This isn't just a press release; it's a strategic pivot toward higher-margin agricultural inputs that could meaningfully diversify Bunge's business beyond the razor-thin margins of commodity trading. For everyday investors, the bottom line is this: Bunge is profitable, growing earnings at 17% annually, trading cheaper than its peers on a growth-adjusted basis, and making smart bets on agriculture's future.

Risk Assessment

PRIMARY RISK: Commodity cycle reversal. BG's 1.24% net margin means a modest compression in crush margins (oilseed processing spread between raw seed and refined oil/meal) could swing earnings negative. The Q3 beat on 'strong crush margins' is the tailwind — but crush margins are volatile and mean-reverting. SECONDARY RISK: FCF remains deeply negative at -$2.656B; if credit markets tighten, refinancing costs could impair capital allocation flexibility and pressure the balance sheet given D/E already 43% above peers. TERTIARY RISK: Price trend — stock declined from ~$119 to ~$96 through multiple positive earnings cycles; institutional distribution at higher prices suggests the market is pricing merger integration risks (Bunge-Viterra combination) or concerns about normalized crush margins post-peak. MITIGATION: (1) Stop at $83.00 = just above book value (~$84.70/share) — if stock breaks book value, the investment thesis is fundamentally impaired; (2) Position sizing at 2.5% caps downside impact; (3) Entry range $97-$103 provides ~3% above current price ceiling, ensuring we don't chase; (4) The maintained 2026 full-year outlook is a near-term fundamental anchor against downside scenarios.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is BG a halal stock?

No, Bunge Global S.A. (BG) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for BG?

Bunge Global S.A. (BG) has a Plutrex AI rating of 68.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is BG a good investment?

According to Plutrex AI, BG has a Buy rating (68.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in BG?

US stocks like BG can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in BG?

Plutrex AI identifies the main risks for BG by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about BG

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open BG in ElBarake